Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology

Nature Reviews Clinical Oncology, Published online: 05 May 2020; doi:10.1038/s41571-020-0383-1The coronavirus disease 19 (COVID-19) pandemic has become the focus of attention worldwide, and herein we seek to highlight the potential problem of ‘collateral mortality’ from delayed or deferred treatments in patients with cancer. We propose potential solutions to ensure continuity of care in the field of surgical oncology.
Source: Nature Reviews Clinical Oncology - Category: Cancer & Oncology Authors: Source Type: research